Summary
Global Markets Directs, Gingivitis - Pipeline Review, H1 2012, provides an overview of the Gingivitis therapeutic pipeline. This report provides information on the therapeutic development for Gingivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gingivitis. Gingivitis - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Gingivitis.
- A review of the Gingivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Gingivitis Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Gingivitis 6
Gingivitis Therapeutics under Development
by Companies 8
Gingivitis Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Gingivitis Therapeutics Products under Development by Companies 11
Gingivitis Therapeutics Products under Investigation by Universities/Institutes 12
Companies Involved in Gingivitis Therapeutics Development 13
Biomedical Development Corporation. 13
Gingivitis Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
Iocide - Drug Profile 19
Product Description 19
Mechanism of Action 19
RD Progress 19
Camella Sinensis - Drug Profile 20
Product Description 20
Mechanism of Action 20
RD Progress 20
PerioPatch - Drug Profile 21
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012PubId=pagenum=1
Tachycardia (Tachyarrhythmias) Pipeline Review, H1 2012
Genital Warts (Condylomata Acuminata) Pipeline Review, H1 2012
Gingivitis Pipeline Review, H1 2012
West Nile Virus Infections Pipeline Review, H1 2012
Pompe Disease Pipeline Review, H1 2012
Bronchiolitis Obliterans Pipeline Review, H1 2012
Cancer Cachexia Pipeline Review, H1 2012
Hyperuricemia Pipeline Review, H1 2012
Sarcoidosis Pipeline Review, H1 2012
Optic Nerve Injury Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
